BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31150720)

  • 1. Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice.
    Xian Y; Lin Y; Cao C; Li L; Wang J; Niu J; Guo Y; Sun Y; Wang Y; Wang W
    Diabetes Res Clin Pract; 2019 Oct; 156():107755. PubMed ID: 31150720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice.
    Xian Y; Gao Y; Lv W; Ma X; Hu J; Chi J; Wang W; Wang Y
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):2009-2017. PubMed ID: 31970441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
    Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H
    Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury.
    Zhang R; Yin L; Zhang B; Shi H; Sun Y; Ji C; Chen J; Wu P; Zhang L; Xu W; Qian H
    Cell Death Dis; 2018 Sep; 9(10):965. PubMed ID: 30237401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous injection of human umbilical cord-derived mesenchymal stem cells ameliorates not only blood glucose but also nephrotic complication of diabetic rats through autophagy-mediated anti-senescent mechanism.
    Li X; Guo L; Chen J; Liang H; Liu Y; Chen W; Zhou L; Shan L; Wang H
    Stem Cell Res Ther; 2023 May; 14(1):146. PubMed ID: 37248536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord mesenchymal stem cells attenuate podocyte injury under high glucose via TLR2 and TLR4 signaling.
    Wang Y; Liu J; Zhang Q; Wang W; Liu Q; Liu S; Song Y; Wang X; Zhang Y; Li S; Yang X; Lv S; Liu G
    Diabetes Res Clin Pract; 2021 Mar; 173():108702. PubMed ID: 33609619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
    Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
    Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
    Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
    Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro.
    Liu B; Ding F; Hu D; Zhou Y; Long C; Shen L; Zhang Y; Zhang D; Wei G
    Stem Cell Res Ther; 2018 Jan; 9(1):7. PubMed ID: 29329595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair.
    Wang W; Wang Y; Chi J; Tan X; Hu J; Ma X; Sun X; Che K; Lv W; Wang Y
    Mol Med; 2022 Dec; 28(1):155. PubMed ID: 36514009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord mesenchymal stem cells reduce oxidative damage and apoptosis in diabetic nephropathy by activating Nrf2.
    Nie P; Bai X; Lou Y; Zhu Y; Jiang S; Zhang L; Tian N; Luo P; Li B
    Stem Cell Res Ther; 2021 Aug; 12(1):450. PubMed ID: 34380544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.
    Chen Y; Qian H; Zhu W; Zhang X; Yan Y; Ye S; Peng X; Li W; Xu W
    Stem Cells Dev; 2011 Jan; 20(1):103-13. PubMed ID: 20446811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crocin Protects Podocytes Against Oxidative Stress and Inflammation Induced by High Glucose Through Inhibition of NF-κB.
    Li S; Liu X; Lei J; Yang J; Tian P; Gao Y
    Cell Physiol Biochem; 2017; 42(4):1481-1492. PubMed ID: 28719912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
    Zhang Z; Niu L; Tang X; Feng R; Yao G; Chen W; Li W; Feng X; Chen H; Sun L
    Nephrol Dial Transplant; 2019 Apr; 34(4):597-605. PubMed ID: 29982691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
    Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
    Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived mesenchymal stem cells ameliorate nephrosis through repair of impaired podocytes.
    Chen Y; Chen J; Wan J; Gao N; Cui J; You D; Zou Z
    Clin Invest Med; 2017 Feb; 40(1):E13-E24. PubMed ID: 28218578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.